Effect of ART on poly functional profile of CD8 responses to Gag and Nef antigen in HIV infected Indian individuals
© Mendiratta et al; licensee BioMed Central Ltd. 2014
Published: 27 May 2014
Poly functional CD8+ T cells have been described most competent in controlling viral replication in late stage of HIV infection.
Multiparametric flow cytometry and intracellular cytokine staining was performed to study the effect of HAART on poly functional responses of CD8+ T lymphocytes to HIV Gag and Nef peptides and polyclonal stimuli in 40 ART naïve and 10 ART treated HIV infected individuals to compare and examine the degree of immune restoration after ART. We analyzed the CD8+ T cell responses (IFN-γ, IL-2, TNF-α, CD107a) and generated fifteen unique subsets using Boolean gating (Flowjo, SPICE-PESTLE software).
Bulk response of HIV-1–specific CD8+ T cells directed against the identified immunodominant peptides in the treated group decreased (average ± SD: Gag: 2.1% ± 2.1% to 1.17% ± 1.17%, p = 0.14; Nef: 2.95 ± 3.23 to 1.33% ± 1.04%, p = 0.14; Polyclonal Activator: 15.16% ± 8.74% to 5.93% ± 8.29%, p = 0.007). The responses were predominantly mono functional in ART naïve individuals, as also shown by their level of responses and contribution towards global responses. Dual function responses were increased in ART treated individuals as compared to naïve study subjects.
We also observed slight increase in IL2 and TNFα secreting CD8+ T cell subsets in ART treated individuals.
Our data indicates that the functional impairment of antigen specific CD8+ T cells in HIV infection is dynamic and can be partially restored with ART. However the data needs to be substantiated on large sample size.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.